Simon MacKenzie, PhD

CEO
REGENHU, Fribourg, Switzerland

I am the CEO of REGENHU, who are an engineering pioneer and global leader in the design, development and manufacture of 3D Bioprinting instruments, Bioprinting software, and the ongoing support required to enable our users in biotech, pharma and leading universities, to achieve their research goals for transformational innovation in tissue engineering, regenerative medicine and drug discovery.

I have more than 20 years experience in business and scientific roles in Pharma, Biotech, Academia and start-up organizations in Japan, the UK, Europe and the US, and have been involved in drug discovery projects in many therapeutic areas, iPSC based cellular assay development, and biomaterials.

REGENHU builds advanced research instruments for our customers today, with a view of creating tools that will provide their manufacturing needs of the future. Our customer-focused approach, visionary outlook, advanced instruments and user-friendly software that helps them perform tasks with accuracy and repeatability is critical to our users success.

Disclosure information not submitted.

Presentation(s):

• Bioprinting human in vitro discovery models

  Monday, February 7, 2022
  12:00 PM – 12:20 PM